119 related articles for article (PubMed ID: 38030063)
21. Assessing a biomarker's ability to reduce invasive procedures in patients with benign lung nodules: Results from the ORACLE study.
Pritchett MA; Sigal B; Bowling MR; Kurman JS; Pitcher T; Springmeyer SC;
PLoS One; 2023; 18(7):e0287409. PubMed ID: 37432960
[TBL] [Abstract][Full Text] [Related]
22. Probability of cancer in lung nodules using sequential volumetric screening up to 12 months: the UKLS trial.
Marcus MW; Duffy SW; Devaraj A; Green BA; Oudkerk M; Baldwin D; Field J
Thorax; 2019 Aug; 74(8):761-767. PubMed ID: 31028232
[TBL] [Abstract][Full Text] [Related]
23. A Comparison of the PanCan Model and Lung-RADS to Assess Cancer Probability Among People With Screening-Detected, Solid Lung Nodules.
Sundaram V; Gould MK; Nair VS
Chest; 2021 Mar; 159(3):1273-1282. PubMed ID: 33393476
[TBL] [Abstract][Full Text] [Related]
24. Probability of cancer in pulmonary nodules detected on first screening CT.
McWilliams A; Tammemagi MC; Mayo JR; Roberts H; Liu G; Soghrati K; Yasufuku K; Martel S; Laberge F; Gingras M; Atkar-Khattra S; Berg CD; Evans K; Finley R; Yee J; English J; Nasute P; Goffin J; Puksa S; Stewart L; Tsai S; Johnston MR; Manos D; Nicholas G; Goss GD; Seely JM; Amjadi K; Tremblay A; Burrowes P; MacEachern P; Bhatia R; Tsao MS; Lam S
N Engl J Med; 2013 Sep; 369(10):910-9. PubMed ID: 24004118
[TBL] [Abstract][Full Text] [Related]
25. The Probability of Lung Cancer in Patients With Incidentally Detected Pulmonary Nodules: Clinical Characteristics and Accuracy of Prediction Models.
Vachani A; Zheng C; Amy Liu IL; Huang BZ; Osuji TA; Gould MK
Chest; 2022 Feb; 161(2):562-571. PubMed ID: 34364866
[TBL] [Abstract][Full Text] [Related]
26. Evaluating the Patient With a Pulmonary Nodule: A Review.
Mazzone PJ; Lam L
JAMA; 2022 Jan; 327(3):264-273. PubMed ID: 35040882
[TBL] [Abstract][Full Text] [Related]
27. Combination of serum ACSL4 levels and low-dose 256-slice spiral CT exhibits the potential in the early screening of lung cancer.
Yu W; Wang L; Liu S; Liu Y; Wang S; Sun X
Medicine (Baltimore); 2023 Feb; 102(5):e32733. PubMed ID: 36749237
[TBL] [Abstract][Full Text] [Related]
28. Clinical Impact and Generalizability of a Computer-Assisted Diagnostic Tool to Risk-Stratify Lung Nodules With CT.
Adams SJ; Madtes DK; Burbridge B; Johnston J; Goldberg IG; Siegel EL; Babyn P; Nair VS; Calhoun ME
J Am Coll Radiol; 2023 Feb; 20(2):232-242. PubMed ID: 36064040
[TBL] [Abstract][Full Text] [Related]
29. A Generalized Deep Learning-Based Diagnostic System for Early Diagnosis of Various Types of Pulmonary Nodules.
Shaffie A; Soliman A; Fraiwan L; Ghazal M; Taher F; Dunlap N; Wang B; van Berkel V; Keynton R; Elmaghraby A; El-Baz A
Technol Cancer Res Treat; 2018 Jan; 17():1533033818798800. PubMed ID: 30244648
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of models for predicting the probability of malignancy in patients with pulmonary nodules.
Li Y; Hu H; Wu Z; Yan G; Wu T; Liu S; Chen W; Lu Z
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32068231
[TBL] [Abstract][Full Text] [Related]
31. Assessment of Fluorodeoxyglucose F18-Labeled Positron Emission Tomography for Diagnosis of High-Risk Lung Nodules.
Maiga AW; Deppen SA; Mercaldo SF; Blume JD; Montgomery C; Vaszar LT; Williamson C; Isbell JM; Rickman OB; Pinkerman R; Lambright ES; Nesbitt JC; Grogan EL
JAMA Surg; 2018 Apr; 153(4):329-334. PubMed ID: 29117314
[TBL] [Abstract][Full Text] [Related]
32. Accurate classification of pulmonary nodules by a combined model of clinical, imaging, and cell-free DNA methylation biomarkers: a model development and external validation study.
He J; Wang B; Tao J; Liu Q; Peng M; Xiong S; Li J; Cheng B; Li C; Jiang S; Qiu X; Yang Y; Ye Z; Zeng F; Zhang J; Liu D; Li W; Chen Z; Zeng Q; Fan JB; Liang W
Lancet Digit Health; 2023 Oct; 5(10):e647-e656. PubMed ID: 37567793
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of Prediction Models for Identifying Malignancy in Pulmonary Nodules Detected via Low-Dose Computed Tomography.
González Maldonado S; Delorme S; Hüsing A; Motsch E; Kauczor HU; Heussel CP; Kaaks R
JAMA Netw Open; 2020 Feb; 3(2):e1921221. PubMed ID: 32058555
[TBL] [Abstract][Full Text] [Related]
34. Autoantibody Signature Enhances the Positive Predictive Power of Computed Tomography and Nodule-Based Risk Models for Detection of Lung Cancer.
Massion PP; Healey GF; Peek LJ; Fredericks L; Sewell HF; Murray A; Robertson JF
J Thorac Oncol; 2017 Mar; 12(3):578-584. PubMed ID: 27615397
[TBL] [Abstract][Full Text] [Related]
35. Using a risk model for probability of cancer in pulmonary nodules.
Liu SQ; Ma XB; Song WM; Li YF; Li N; Wang LN; Liu JY; Tao NN; Li SJ; Xu TT; Zhang QY; An QQ; Liang B; Li HC
Thorac Cancer; 2021 Jun; 12(12):1881-1889. PubMed ID: 33973725
[TBL] [Abstract][Full Text] [Related]
36. Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report.
Mazzone PJ; Gould MK; Arenberg DA; Chen AC; Choi HK; Detterbeck FC; Farjah F; Fong KM; Iaccarino JM; Janes SM; Kanne JP; Kazerooni EA; MacMahon H; Naidich DP; Powell CA; Raoof S; Rivera MP; Tanner NT; Tanoue LK; Tremblay A; Vachani A; White CS; Wiener RS; Silvestri GA
Chest; 2020 Jul; 158(1):406-415. PubMed ID: 32335067
[TBL] [Abstract][Full Text] [Related]
37. An integrated segmentation and shape-based classification scheme for distinguishing adenocarcinomas from granulomas on lung CT.
Alilou M; Beig N; Orooji M; Rajiah P; Velcheti V; Rakshit S; Reddy N; Yang M; Jacono F; Gilkeson RC; Linden P; Madabhushi A
Med Phys; 2017 Jul; 44(7):3556-3569. PubMed ID: 28295386
[TBL] [Abstract][Full Text] [Related]
38. Comparative Study of Autoantibody Responses between Lung Adenocarcinoma and Benign Pulmonary Nodules.
Wang J; Shivakumar S; Barker K; Tang Y; Wallstrom G; Park JG; Tsay JC; Pass HI; Rom WN; LaBaer J; Qiu J
J Thorac Oncol; 2016 Mar; 11(3):334-45. PubMed ID: 26896032
[TBL] [Abstract][Full Text] [Related]
39. Relationship between the number of new nodules and lung cancer probability in incidence screening rounds of CT lung cancer screening: The NELSON study.
Walter JE; Heuvelmans MA; de Bock GH; Yousaf-Khan U; Groen HJM; van der Aalst CM; Nackaerts K; van Ooijen PMA; de Koning HJ; Vliegenthart R; Oudkerk M
Lung Cancer; 2018 Nov; 125():103-108. PubMed ID: 30429006
[TBL] [Abstract][Full Text] [Related]
40. Feasibility of lung cancer prediction from low-dose CT scan and smoking factors using causal models.
Raghu VK; Zhao W; Pu J; Leader JK; Wang R; Herman J; Yuan JM; Benos PV; Wilson DO
Thorax; 2019 Jul; 74(7):643-649. PubMed ID: 30862725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
